ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 357 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $4,704,000 | -30.2% | 116,376 | -0.6% | 0.01% | -25.0% |
| Q2 2015 | $6,741,000 | -73.8% | 117,136 | -71.1% | 0.01% | -76.5% |
| Q1 2015 | $25,762,000 | +13.3% | 404,622 | +9.9% | 0.03% | +13.3% |
| Q4 2014 | $22,733,000 | +73.7% | 368,206 | +9.2% | 0.03% | +66.7% |
| Q3 2014 | $13,090,000 | +13.3% | 337,105 | +0.5% | 0.02% | +12.5% |
| Q2 2014 | $11,556,000 | -13.8% | 335,453 | +8.1% | 0.02% | -15.8% |
| Q1 2014 | $13,408,000 | +9.0% | 310,292 | +0.5% | 0.02% | +5.6% |
| Q4 2013 | $12,305,000 | +3.7% | 308,852 | -2.3% | 0.02% | -10.0% |
| Q3 2013 | $11,866,000 | +48.5% | 316,098 | +6.3% | 0.02% | +42.9% |
| Q2 2013 | $7,990,000 | – | 297,376 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,634,838 | $268,180,000 | 8.50% |
| DOWLING & YAHNKE LLC | 676,379 | $27,339,000 | 3.72% |
| WILLIAM HARRIS INVESTORS INC | 317,301 | $12,826,000 | 3.63% |
| Opus Point Partners Management, LLC | 101,401 | $4,099,000 | 2.26% |
| SOUND ENERGY PARTNERS, INC. | 25,000 | $1,011,000 | 2.04% |
| Sonora Investment Management, LLC | 127,104 | $6,622,000 | 2.00% |
| PINNACLE ASSOCIATES LTD | 1,778,325 | $71,880,000 | 1.59% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 17,000 | $687,000 | 1.36% |
| Apex Capital Management | 1,019,618 | $41,213,000 | 0.93% |
| PERKINS CAPITAL MANAGEMENT INC | 20,350 | $823,000 | 0.92% |